138 related articles for article (PubMed ID: 30863134)
1. Development and psychometric evaluation of the Diabetic Gastroparesis Symptom Severity Diary.
Fehnel S; Fiedorek FT; Nelson L; DiBenedetti D; Spence S; Carson RT
Clin Exp Gastroenterol; 2019; 12():93-103. PubMed ID: 30863134
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Relamorelin in Diabetics With Symptoms of Gastroparesis: A Randomized, Placebo-Controlled Study.
Camilleri M; McCallum RW; Tack J; Spence SC; Gottesdiener K; Fiedorek FT
Gastroenterology; 2017 Nov; 153(5):1240-1250.e2. PubMed ID: 28760384
[TBL] [Abstract][Full Text] [Related]
3. Evaluating symptom outcomes in gastroparesis clinical trials: validity and responsiveness of the Gastroparesis Cardinal Symptom Index-Daily Diary (GCSI-DD).
Revicki DA; Camilleri M; Kuo B; Szarka LA; McCormack J; Parkman HP
Neurogastroenterol Motil; 2012 May; 24(5):456-63, e215-6. PubMed ID: 22284754
[TBL] [Abstract][Full Text] [Related]
4. Relamorelin Reduces Vomiting Frequency and Severity and Accelerates Gastric Emptying in Adults With Diabetic Gastroparesis.
Lembo A; Camilleri M; McCallum R; Sastre R; Breton C; Spence S; White J; Currie M; Gottesdiener K; Stoner E;
Gastroenterology; 2016 Jul; 151(1):87-96.e6. PubMed ID: 27055601
[TBL] [Abstract][Full Text] [Related]
5. The American neurogastroenterology and motility society gastroparesis cardinal symptom index-daily diary (ANMS GCSI-DD): Psychometric evaluation in patients with idiopathic or diabetic gastroparesis.
Revicki DA; Speck RM; Lavoie S; Puelles J; Kuo B; Camilleri M; Almansa C; Parkman HP
Neurogastroenterol Motil; 2019 Apr; 31(4):e13553. PubMed ID: 30734412
[TBL] [Abstract][Full Text] [Related]
6. Early satiety and postprandial fullness in gastroparesis correlate with gastroparesis severity, gastric emptying, and water load testing.
Parkman HP; Hallinan EK; Hasler WL; Farrugia G; Koch KL; Nguyen L; Snape WJ; Abell TL; McCallum RW; Sarosiek I; Pasricha PJ; Clarke J; Miriel L; Tonascia J; Hamilton F;
Neurogastroenterol Motil; 2017 Apr; 29(4):. PubMed ID: 27781342
[TBL] [Abstract][Full Text] [Related]
7. Relamorelin for the treatment of gastrointestinal motility disorders.
Chedid V; Camilleri M
Expert Opin Investig Drugs; 2017 Oct; 26(10):1189-1197. PubMed ID: 28847163
[TBL] [Abstract][Full Text] [Related]
8. The content validity of the ANMS GCSI-DD in patients with idiopathic or diabetic gastroparesis.
Revicki DA; Lavoie S; Speck RM; Puelles J; Kuo B; Camilleri M; Almansa C; Parkman HP
J Patient Rep Outcomes; 2018 Dec; 2(1):61. PubMed ID: 30547386
[TBL] [Abstract][Full Text] [Related]
9. Development and content validity of a gastroparesis cardinal symptom index daily diary.
Revicki DA; Camilleri M; Kuo B; Norton NJ; Murray L; Palsgrove A; Parkman HP
Aliment Pharmacol Ther; 2009 Sep; 30(6):670-80. PubMed ID: 19558608
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic response to domperidone in gastroparesis: A prospective study using the GCSI-daily diary.
Heckert J; Parkman HP
Neurogastroenterol Motil; 2018 Jan; 30(1):. PubMed ID: 29110425
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of the Axillary Sweating Daily Diary: a patient-reported outcome measure to assess axillary sweating severity.
Nelson LM; DiBenedetti D; Pariser DM; Glaser DA; Hebert AA; Hofland H; Drew J; Ingolia D; Gillard KK; Fehnel S
J Patient Rep Outcomes; 2019 Sep; 3(1):59. PubMed ID: 31486951
[TBL] [Abstract][Full Text] [Related]
12. Randomized clinical trial: a controlled pilot trial of the 5-HT4 receptor agonist revexepride in patients with symptoms suggestive of gastroparesis.
Tack J; Rotondo A; Meulemans A; Thielemans L; Cools M
Neurogastroenterol Motil; 2016 Apr; 28(4):487-97. PubMed ID: 27010235
[TBL] [Abstract][Full Text] [Related]
13. Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms.
Revicki DA; Rentz AM; Dubois D; Kahrilas P; Stanghellini V; Talley NJ; Tack J
Qual Life Res; 2004 May; 13(4):833-44. PubMed ID: 15129893
[TBL] [Abstract][Full Text] [Related]
14. Abdominal pain is a frequent symptom of gastroparesis.
Cherian D; Sachdeva P; Fisher RS; Parkman HP
Clin Gastroenterol Hepatol; 2010 Aug; 8(8):676-81. PubMed ID: 20472097
[TBL] [Abstract][Full Text] [Related]
15. Nausea and vomiting in diabetic and idiopathic gastroparesis.
Cherian D; Parkman HP
Neurogastroenterol Motil; 2012 Mar; 24(3):217-22, e103. PubMed ID: 22118574
[TBL] [Abstract][Full Text] [Related]
16. Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders.
Rentz AM; Kahrilas P; Stanghellini V; Tack J; Talley NJ; de la Loge C; Trudeau E; Dubois D; Revicki DA
Qual Life Res; 2004 Dec; 13(10):1737-49. PubMed ID: 15651544
[TBL] [Abstract][Full Text] [Related]
17. Diabetic Gastroparesis and its Emerging Therapeutic Options: A Narrative Review of the Literature.
Zahid SA; Tated R; Mathew M; Rajkumar D; Karnik SB; Pramod Roy A; Jacob FP; Baskara Salian R; Razzaq W; Shivakumar D; Khawaja UA
Cureus; 2023 Sep; 15(9):e44870. PubMed ID: 37814758
[TBL] [Abstract][Full Text] [Related]
18. Gastric electrical stimulation: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(16):1-79. PubMed ID: 23074486
[TBL] [Abstract][Full Text] [Related]
19. Development of an electronic daily uterine fibroid symptom diary.
Deal LS; Williams VS; Fehnel SE
Patient; 2011; 4(1):31-44. PubMed ID: 21766892
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Ghrelin Agonists in Patients with Diabetic Gastroparesis: A Systematic Review and Meta-Analysis.
Hong SW; Chun J; Kim J; Lee J; Lee HJ; Chung H; Cho SJ; Im JP; Kim SG; Kim JS
Gut Liver; 2020 Sep; 14(5):589-600. PubMed ID: 31816671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
